1. Home
  2. QTTB vs TTI Comparison

QTTB vs TTI Comparison

Compare QTTB & TTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTTB
  • TTI
  • Stock Information
  • Founded
  • QTTB 2015
  • TTI 1981
  • Country
  • QTTB United States
  • TTI United States
  • Employees
  • QTTB N/A
  • TTI N/A
  • Industry
  • QTTB Biotechnology: Pharmaceutical Preparations
  • TTI Oil & Gas Production
  • Sector
  • QTTB Health Care
  • TTI Energy
  • Exchange
  • QTTB Nasdaq
  • TTI Nasdaq
  • Market Cap
  • QTTB 434.0M
  • TTI 507.5M
  • IPO Year
  • QTTB N/A
  • TTI 1990
  • Fundamental
  • Price
  • QTTB $3.31
  • TTI $3.48
  • Analyst Decision
  • QTTB Buy
  • TTI Strong Buy
  • Analyst Count
  • QTTB 8
  • TTI 4
  • Target Price
  • QTTB $29.14
  • TTI $7.13
  • AVG Volume (30 Days)
  • QTTB 690.6K
  • TTI 816.2K
  • Earning Date
  • QTTB 11-07-2024
  • TTI 10-29-2024
  • Dividend Yield
  • QTTB N/A
  • TTI N/A
  • EPS Growth
  • QTTB N/A
  • TTI N/A
  • EPS
  • QTTB N/A
  • TTI 0.01
  • Revenue
  • QTTB N/A
  • TTI $617,733,000.00
  • Revenue This Year
  • QTTB N/A
  • TTI N/A
  • Revenue Next Year
  • QTTB N/A
  • TTI $12.65
  • P/E Ratio
  • QTTB N/A
  • TTI $271.35
  • Revenue Growth
  • QTTB N/A
  • TTI N/A
  • 52 Week Low
  • QTTB $3.02
  • TTI $2.68
  • 52 Week High
  • QTTB $53.79
  • TTI $5.08
  • Technical
  • Relative Strength Index (RSI)
  • QTTB 16.87
  • TTI 41.74
  • Support Level
  • QTTB $3.02
  • TTI $3.33
  • Resistance Level
  • QTTB $3.77
  • TTI $3.86
  • Average True Range (ATR)
  • QTTB 1.69
  • TTI 0.20
  • MACD
  • QTTB -0.34
  • TTI -0.05
  • Stochastic Oscillator
  • QTTB 1.16
  • TTI 23.08

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

About TTI Tetra Technologies Inc.

Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. The Water & Flowback Services Division provides onshore oil and gas operators with comprehensive water management services. The company derives maximum revenue from United states.

Share on Social Networks: